Produkty 2765008-88-4

CAS 2765008-88-4 występuje w naszej ofercie pod nazwami: (E)-4-Oxo-4-(4-undecylphenyl)but-2-enoic acid, 98%, 98%, Atg4B-IN-2/ 98.86% (existing batch purity), Atg4B-IN-2 98%, Atg4B-IN-2, 98.03%. Oferty producentów: Chemat, TargetMol, Ambeed, MedChemExpress. Dostępne opakowania: 5mg, 10mg, 25mg, 50mg, 100mg, 1mg, 250mg, 5 mg.

(E)-4-Oxo-4-(4-undecylphenyl)but-2-enoic acid, 98%, 98%
Chemat
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 5
od 539,60
Zobacz produkt
Atg4B-IN-2/ 98.86% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 923,91
Zobacz produkt
Atg4B-IN-2 98%
Ambeed
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 6
od 698,56
Zobacz produkt
Atg4B-IN-2, 98.03%
MedChemExpress
  • opakowanie: 5 mg, 10 mg
  • Warianty: 2
od 1462,12
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E)-4-oxo-4-(4-undecylphenyl)but-2-enoic acid (CAS 2765008-88-4) to związek chemiczny o wzorze sumarycznym C21H30O3 i masie molowej 330.5 g/mol. Nazwa systematyczna IUPAC: (E)-4-oxo-4-(4-undecylphenyl)but-2-enoic acid. InChIKey: XEPLKXYXNJMMCI-WUKNDPDISA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O3
Masa molowa330.5 g/mol
Nazwa IUPAC(E)-4-oxo-4-(4-undecylphenyl)but-2-enoic acid
InChIKeyXEPLKXYXNJMMCI-WUKNDPDISA-N
SMILESCCCCCCCCCCCC1=CC=C(C=C1)C(=O)/C=C/C(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Atg4B-IN-2, (E)-4-oxo-4-(4-undecylphenyl)but-2-enoic acid, orb1689068, 2-Butenoic acid, 4-oxo-4-(4-undecylphenyl)-, (2E)-
Izomery (ten sam wzór sumaryczny)
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
(1R,2R,4R,5R,7S,10R,11S,14S,16S,18S,19S)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one C21H30O3
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O3
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O3
methyl (8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylate C21H30O3
[(7R,8R,9S,10R,13S,14S,17S)-7,13-dimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O3
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O3
[(1S,2S,4R,6S,8S,11R,12S,16S)-2,16-dimethyl-5-oxapentacyclo[9.7.0.02,8.04,6.012,16]octadec-14-en-15-yl] acetate C21H30O3
(8S,9S,10R,13S,14S,16R,17R)-17-acetyl-16-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(6R,8S,9S,10R,13S,14S,17S)-17-acetyl-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3
(2E,4E,6E,8E)-9-(3-methoxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid C21H30O3
(8S,9S,10R,13S,14S,17S)-17-acetyl-6-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O3